Finally, we demonstrated that R788, in combination with anti-PDL1 mAb treatment, elicit robust anti-tumor effects in mice bearing small (50 mm3) NB9464 tumors and, when combined with radiation, prolonged survival of mice bearing large NB9464 tumors. This evidence concerns the gene CD274 and neoplasm.